Literature DB >> 35745169

Comment on Kremer et al. Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies. Nutrients 2021, 13, 3069.

Rob Janssen1, Jona Walk2, Cees Vermeer3.   

Abstract

In the article "Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies", Kremer et al. [...].

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35745169      PMCID: PMC9228108          DOI: 10.3390/nu14122439

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   6.706


In the article “Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies”, Kremer et al. measured plasma levels of dephosphorylated-uncarboxylated matrix Gla protein (dp-ucMGP) in patients with chronic renal failure (CRF) and correlated these with plasma creatinine [1]. MGP is a vitamin K-dependent calcification inhibitor that may undergo two activation steps—phosphorylation and carboxylation—creating four MGP variants: 1. dp-ucMGP; 2. phosphorylated-carboxylated (p-c)MGP; 3. p-ucMGP; and 4. dp-cMGP [2]. Circulating dp-ucMGP reflects vitamin K status with high and low dp-ucMGP levels representing vitamin K deficiency and sufficiency, respectively [2]. Kremer et al. demonstrated that dp-ucMGP positively correlates with creatinine in CRF patients and concluded that dp-ucMGP should therefore be corrected for kidney function [1]. However, a correlation between a biomarker and kidney function does not automatically imply that it should be corrected for creatinine. Adjustment would only be appropriate if the rise is caused by a fall in renal function. Rennenberg et al., however, demonstrated that the average renal fractional extraction of MGP is independent of kidney function in hypertensive patients [3]. Theoretically, it could be the case that MGP variants in CRF are differentially excreted in urine, but Kremer et al. did not provide convincing evidence for this [1]. The correlation between dp-ucMGP and creatinine in CRF likely reflects a mechanistic link. Vascular calcification is prevalent in CRF due to disorders in mineral metabolism and increases as the glomerular filtration rate declines [4]. Calcium deposition leads to MGP upregulation to protect blood vessels from further mineralization [5]. MGP, however, is only functional after vitamin K-dependent carboxylation [6]. Activation of synthesized MGP may lead to depletion of vitamin K stores and subsequent vitamin K deficiency, which is reflected by increased dp-ucMGP levels. Adequate levels of cMGP are crucial to maintain the patency of blood vessels [5]. In a state of vitamin K deficiency, there is insufficient cMGP activity in the kidneys, exacerbating vascular deterioration and renal failure [7]. We conclude that the correlation between dp-ucMGP and creatinine is far more likely the result of vitamin K deficiency than a function of a decreased glomerular filtration rate. Regardless of any renal influence on dp-ucMGP levels, elevated dp-ucMGP levels should, in our opinion, be normalized by vitamin K administration and not through adjusting for creatinine.
  7 in total

1.  The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats.

Authors:  P A Price; J R Buckley; M K Williamson
Journal:  J Nutr       Date:  2001-11       Impact factor: 4.798

Review 2.  Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?

Authors:  Stefanos Roumeliotis; Athanasios Roumeliotis; Evangelia Dounousi; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Curr Vasc Pharmacol       Date:  2021       Impact factor: 2.719

Review 3.  Matrix Gla-protein: the calcification inhibitor in need of vitamin K.

Authors:  Leon J Schurgers; Ellen C M Cranenburg; Cees Vermeer
Journal:  Thromb Haemost       Date:  2008-10       Impact factor: 5.249

4.  Renal handling of matrix Gla-protein in humans with moderate to severe hypertension.

Authors:  Roger J M W Rennenberg; Leon J Schurgers; Cees Vermeer; Jan B J Scholte; Alphons J H M Houben; Peter W de Leeuw; Abraham A Kroon
Journal:  Hypertens Res       Date:  2008-09       Impact factor: 3.872

Review 5.  Vascular calcification in chronic kidney disease: role of disordered mineral metabolism.

Authors:  Shyamal Palit; Jessica Kendrick
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 6.  Vitamin K-Dependent Matrix Gla Protein as Multifaceted Protector of Vascular and Tissue Integrity.

Authors:  Fang-Fei Wei; Sander Trenson; Peter Verhamme; Cees Vermeer; Jan A Staessen
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

  7 in total
  1 in total

1.  Reply to Janssen et al. Comment on "Kremer et al. Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies. Nutrients 2021, 13, 3069".

Authors:  Daan Kremer; Dion Groothof; Charlotte A Keyzer; Coby Eelderink; Tim J Knobbe; Adrian Post; Marco van Londen; Michele F Eisenga; Leon J Schurgers; Stefan P Berger; Martin H de Borst; Stephan J L Bakker
Journal:  Nutrients       Date:  2022-06-13       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.